ARTICLE | Finance
Regulatory milestones
January 4, 2010 8:00 AM UTC
Arena Pharmaceuticals Inc. (NASDAQ:ARNA) was off $0.11 to $3.64 Christmas week after submitting an NDA to FDA for lorcaserin for weight management.
Basilea Pharmaceutica AG (SIX:BSLN) fell CHF11.70 (15%) to CHF64.45 last Wednesday after FDA issued a complete response letter for an NDA from partner Johnson & Johnson (NYSE:JNJ) for ceftobiprole to treat complicated skin and skin structure infections (cSSSIs). For the week, Basilea lost CHF13.05 (17%) to CHF64.45 (see B10)...